MedTrace Logo

Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer

NCT03923309 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2019-04-22

No results posted yet for this study

Summary

Though refusal of radical surgery was often happened in rectal cancer patient after neoadjuvant chemoradiotherapy, little is currently known about the actual oncologic outcome of it. Thus the investigators designed this study to compare the oncologic outcome of unintended rectal preservation with intended rectal preservation by surgeon.

Conditions

Sponsors & Collaborators

  • National Cancer Center, Korea

    collaborator OTHER_GOV

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jae-Hwan Oh, Ph.D. · National Cancer Center, Korea

  • Kyu Joo Park, Ph.D. · Seoul National University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2017-12-30
Completion
2017-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03923309 on ClinicalTrials.gov